Skip to content

Clinical trials

Phase 2/3 Substance-Related Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 2/3 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20052
20063
20083
20093
20101
20111
20122
20141
20162
20201
20212
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Unknown status2
Recruiting1
Suspended1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University4
University of California, Los Angeles2
Virginia Commonwealth University2
Arizona State University1
Boston Children's Hospital1
Coatesville VA Medical Center1
Columbia University1
ContinueYou, LLC1
Friends Research Institute, Inc.1
Gavin Bart1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders27
Alcoholism3
Cocaine-Related Disorders3
Marijuana Abuse3
Opioid-Related Disorders3
COVID-191
Disease1
Emergencies1
Fractures, Stress1
Gram-Positive Bacterial Infections1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.